Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial
Mostly affecting women of reproductive age, lymphangiomyomatosis (LAM) is a rare cystic lung illness that is characterized by the growth of aberrant smooth muscle-like neoplastic cdb. Pulmonary, lymphatic, and renal involvement are some of the clinical symptoms, as shown by lung cysts, pneumothorace...
Gespeichert in:
| Veröffentlicht in: | Annals of the American Thoracic Society 2023-07, Vol.20 (7), p.1073-1076 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1076 |
|---|---|
| container_issue | 7 |
| container_start_page | 1073 |
| container_title | Annals of the American Thoracic Society |
| container_volume | 20 |
| creator | Matthew, Brianna P Lebron, Alfredo Chen, Yun-Ching Lohr, Wesley H Rollison, Shirley F Worthy, Tatyana A Jones, Amanda M Julien-Williams, Patricia Pirooznia, Mehdi Chen, Marcus Y Moss, Joel Wen, Han |
| description | Mostly affecting women of reproductive age, lymphangiomyomatosis (LAM) is a rare cystic lung illness that is characterized by the growth of aberrant smooth muscle-like neoplastic cdb. Pulmonary, lymphatic, and renal involvement are some of the clinical symptoms, as shown by lung cysts, pneumothoraces, and lymphangioleiomyomas. As pulmonary dilution tests (PlTs) diminish, pulmonary cysts develop. These include the lung carbon monoxide diffusing capacity adjusted for hemoglobin (% predicted), forced expiratory volume in one second (% predicted), and the ratio of forced vital capacity to forced expiratory volume in one second (% predicted), referred to as l)iH, adj (% predicted). FEV, (% expected), and i;EV,/FVC, are given on a scale of 1 to 5. |
| doi_str_mv | 10.1513/AnnalsATS.202212-1003RL |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2832574052</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2832838424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-6cd412ad923b03324e95e7b9c792ed79a808ca980123d7f446199044d93846453</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EolXpXwBLXLik-CuJzS1K-ZIiQHQ5R17H6U7lxIvtgPJD-n_r3S09MJcZjd95rZkHoTeUXNGS8vfNPGsXm83NFSOMUVZQQvjP7hk6Z5yVRVUx-vxYq6JSnJ-hyxjvSA5ZUlmrl-iM5z6puTxH99_8H-vwj8VNftZhxe0aE253OmiTbICYwETcxOgN6GQH_BfSDqedxdcwjkuE-Ra3eq8NpBX78fjSLbkJM-7Wab_T8y14Z8FPq5908hHiB9zgNvgYixtrEuR_HW4dzGBysQmg3Sv0Yswr2svHfIF-ffq4ab8U3ffPX9umKwwXNBWVGQRlelCMbwnnTFhV2nqrTK2YHWqlJZFGK0ko40M9ClFRpYgQg-JSVKLkF-jdyXcf_O_FxtRPEI11Ts_WL7FnMh-0FqRkWfr2P-mdX8IBxFElsyMTWVWfVOawX7Bjvw8w5bv2lPQHeP0TvP4Erz_By5OvH_2X7WSHp7l_qPgDZpWYJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2832838424</pqid></control><display><type>article</type><title>Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial</title><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Matthew, Brianna P ; Lebron, Alfredo ; Chen, Yun-Ching ; Lohr, Wesley H ; Rollison, Shirley F ; Worthy, Tatyana A ; Jones, Amanda M ; Julien-Williams, Patricia ; Pirooznia, Mehdi ; Chen, Marcus Y ; Moss, Joel ; Wen, Han</creator><creatorcontrib>Matthew, Brianna P ; Lebron, Alfredo ; Chen, Yun-Ching ; Lohr, Wesley H ; Rollison, Shirley F ; Worthy, Tatyana A ; Jones, Amanda M ; Julien-Williams, Patricia ; Pirooznia, Mehdi ; Chen, Marcus Y ; Moss, Joel ; Wen, Han</creatorcontrib><description>Mostly affecting women of reproductive age, lymphangiomyomatosis (LAM) is a rare cystic lung illness that is characterized by the growth of aberrant smooth muscle-like neoplastic cdb. Pulmonary, lymphatic, and renal involvement are some of the clinical symptoms, as shown by lung cysts, pneumothoraces, and lymphangioleiomyomas. As pulmonary dilution tests (PlTs) diminish, pulmonary cysts develop. These include the lung carbon monoxide diffusing capacity adjusted for hemoglobin (% predicted), forced expiratory volume in one second (% predicted), and the ratio of forced vital capacity to forced expiratory volume in one second (% predicted), referred to as l)iH, adj (% predicted). FEV, (% expected), and i;EV,/FVC, are given on a scale of 1 to 5.</description><identifier>ISSN: 2329-6933</identifier><identifier>EISSN: 2325-6621</identifier><identifier>DOI: 10.1513/AnnalsATS.202212-1003RL</identifier><identifier>PMID: 36930738</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Chronic obstructive pulmonary disease ; Clinical trials ; Lung cancer ; Lung diseases ; Pulmonary hypertension</subject><ispartof>Annals of the American Thoracic Society, 2023-07, Vol.20 (7), p.1073-1076</ispartof><rights>Copyright American Thoracic Society Jul 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-6cd412ad923b03324e95e7b9c792ed79a808ca980123d7f446199044d93846453</citedby><cites>FETCH-LOGICAL-c341t-6cd412ad923b03324e95e7b9c792ed79a808ca980123d7f446199044d93846453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36930738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matthew, Brianna P</creatorcontrib><creatorcontrib>Lebron, Alfredo</creatorcontrib><creatorcontrib>Chen, Yun-Ching</creatorcontrib><creatorcontrib>Lohr, Wesley H</creatorcontrib><creatorcontrib>Rollison, Shirley F</creatorcontrib><creatorcontrib>Worthy, Tatyana A</creatorcontrib><creatorcontrib>Jones, Amanda M</creatorcontrib><creatorcontrib>Julien-Williams, Patricia</creatorcontrib><creatorcontrib>Pirooznia, Mehdi</creatorcontrib><creatorcontrib>Chen, Marcus Y</creatorcontrib><creatorcontrib>Moss, Joel</creatorcontrib><creatorcontrib>Wen, Han</creatorcontrib><title>Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial</title><title>Annals of the American Thoracic Society</title><addtitle>Ann Am Thorac Soc</addtitle><description>Mostly affecting women of reproductive age, lymphangiomyomatosis (LAM) is a rare cystic lung illness that is characterized by the growth of aberrant smooth muscle-like neoplastic cdb. Pulmonary, lymphatic, and renal involvement are some of the clinical symptoms, as shown by lung cysts, pneumothoraces, and lymphangioleiomyomas. As pulmonary dilution tests (PlTs) diminish, pulmonary cysts develop. These include the lung carbon monoxide diffusing capacity adjusted for hemoglobin (% predicted), forced expiratory volume in one second (% predicted), and the ratio of forced vital capacity to forced expiratory volume in one second (% predicted), referred to as l)iH, adj (% predicted). FEV, (% expected), and i;EV,/FVC, are given on a scale of 1 to 5.</description><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical trials</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>Pulmonary hypertension</subject><issn>2329-6933</issn><issn>2325-6621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi0EolXpXwBLXLik-CuJzS1K-ZIiQHQ5R17H6U7lxIvtgPJD-n_r3S09MJcZjd95rZkHoTeUXNGS8vfNPGsXm83NFSOMUVZQQvjP7hk6Z5yVRVUx-vxYq6JSnJ-hyxjvSA5ZUlmrl-iM5z6puTxH99_8H-vwj8VNftZhxe0aE253OmiTbICYwETcxOgN6GQH_BfSDqedxdcwjkuE-Ra3eq8NpBX78fjSLbkJM-7Wab_T8y14Z8FPq5908hHiB9zgNvgYixtrEuR_HW4dzGBysQmg3Sv0Yswr2svHfIF-ffq4ab8U3ffPX9umKwwXNBWVGQRlelCMbwnnTFhV2nqrTK2YHWqlJZFGK0ko40M9ClFRpYgQg-JSVKLkF-jdyXcf_O_FxtRPEI11Ts_WL7FnMh-0FqRkWfr2P-mdX8IBxFElsyMTWVWfVOawX7Bjvw8w5bv2lPQHeP0TvP4Erz_By5OvH_2X7WSHp7l_qPgDZpWYJQ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Matthew, Brianna P</creator><creator>Lebron, Alfredo</creator><creator>Chen, Yun-Ching</creator><creator>Lohr, Wesley H</creator><creator>Rollison, Shirley F</creator><creator>Worthy, Tatyana A</creator><creator>Jones, Amanda M</creator><creator>Julien-Williams, Patricia</creator><creator>Pirooznia, Mehdi</creator><creator>Chen, Marcus Y</creator><creator>Moss, Joel</creator><creator>Wen, Han</creator><general>American Thoracic Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>202307</creationdate><title>Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial</title><author>Matthew, Brianna P ; Lebron, Alfredo ; Chen, Yun-Ching ; Lohr, Wesley H ; Rollison, Shirley F ; Worthy, Tatyana A ; Jones, Amanda M ; Julien-Williams, Patricia ; Pirooznia, Mehdi ; Chen, Marcus Y ; Moss, Joel ; Wen, Han</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-6cd412ad923b03324e95e7b9c792ed79a808ca980123d7f446199044d93846453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical trials</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>Pulmonary hypertension</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matthew, Brianna P</creatorcontrib><creatorcontrib>Lebron, Alfredo</creatorcontrib><creatorcontrib>Chen, Yun-Ching</creatorcontrib><creatorcontrib>Lohr, Wesley H</creatorcontrib><creatorcontrib>Rollison, Shirley F</creatorcontrib><creatorcontrib>Worthy, Tatyana A</creatorcontrib><creatorcontrib>Jones, Amanda M</creatorcontrib><creatorcontrib>Julien-Williams, Patricia</creatorcontrib><creatorcontrib>Pirooznia, Mehdi</creatorcontrib><creatorcontrib>Chen, Marcus Y</creatorcontrib><creatorcontrib>Moss, Joel</creatorcontrib><creatorcontrib>Wen, Han</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the American Thoracic Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matthew, Brianna P</au><au>Lebron, Alfredo</au><au>Chen, Yun-Ching</au><au>Lohr, Wesley H</au><au>Rollison, Shirley F</au><au>Worthy, Tatyana A</au><au>Jones, Amanda M</au><au>Julien-Williams, Patricia</au><au>Pirooznia, Mehdi</au><au>Chen, Marcus Y</au><au>Moss, Joel</au><au>Wen, Han</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial</atitle><jtitle>Annals of the American Thoracic Society</jtitle><addtitle>Ann Am Thorac Soc</addtitle><date>2023-07</date><risdate>2023</risdate><volume>20</volume><issue>7</issue><spage>1073</spage><epage>1076</epage><pages>1073-1076</pages><issn>2329-6933</issn><eissn>2325-6621</eissn><abstract>Mostly affecting women of reproductive age, lymphangiomyomatosis (LAM) is a rare cystic lung illness that is characterized by the growth of aberrant smooth muscle-like neoplastic cdb. Pulmonary, lymphatic, and renal involvement are some of the clinical symptoms, as shown by lung cysts, pneumothoraces, and lymphangioleiomyomas. As pulmonary dilution tests (PlTs) diminish, pulmonary cysts develop. These include the lung carbon monoxide diffusing capacity adjusted for hemoglobin (% predicted), forced expiratory volume in one second (% predicted), and the ratio of forced vital capacity to forced expiratory volume in one second (% predicted), referred to as l)iH, adj (% predicted). FEV, (% expected), and i;EV,/FVC, are given on a scale of 1 to 5.</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>36930738</pmid><doi>10.1513/AnnalsATS.202212-1003RL</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2329-6933 |
| ispartof | Annals of the American Thoracic Society, 2023-07, Vol.20 (7), p.1073-1076 |
| issn | 2329-6933 2325-6621 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2832574052 |
| source | American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection |
| subjects | Chronic obstructive pulmonary disease Clinical trials Lung cancer Lung diseases Pulmonary hypertension |
| title | Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T20%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Pulmonary%20Cyst%20Characteristics%20Associated%20with%20the%20Diffusing%20Capacity%20of%20the%20Lung%20in%20Lymphangioleiomyomatosis:%20A%20Cross-Sectional%20Clinical%20Trial&rft.jtitle=Annals%20of%20the%20American%20Thoracic%20Society&rft.au=Matthew,%20Brianna%20P&rft.date=2023-07&rft.volume=20&rft.issue=7&rft.spage=1073&rft.epage=1076&rft.pages=1073-1076&rft.issn=2329-6933&rft.eissn=2325-6621&rft_id=info:doi/10.1513/AnnalsATS.202212-1003RL&rft_dat=%3Cproquest_cross%3E2832838424%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2832838424&rft_id=info:pmid/36930738&rfr_iscdi=true |